K. Tsurui

Population Pharmacokinetic and Exposure–Response Analysis of Weekly Teriparatide in Osteoporosis Patients

Y. Tanigawara, K. Yamashita, A. Ose, 2017, Journal of clinical pharmacology.

Contribution of cytochrome P450 and UDT-glucuronosyltransferase to the metabolism of drugs containing carboxylic acid groups: risk assessment of acylglucuronides using human hepatocytes

S. Yamada, K. Tsurui, N. Jinno, 2014, Xenobiotica; the fate of foreign compounds in biological systems.

Pharmacological profile of hydroxy fasudil as a selective rho kinase inhibitor on ischemic brain damage.

T. Kobayashi, T. Utsunomiya, K. Tsurui, 2001, Life sciences.

Evaluation of drug–drug interaction between the novel cPLA2 inhibitor AK106-001616 and methotrexate in rheumatoid arthritis patients

K. Sugiyama, K. Yamanishi, K. Tsurui, 2015, Xenobiotica; the fate of foreign compounds in biological systems.

Vitamin A protects the small intestine from methotrexate-induced damage in rats.

T. Horie, S. Awazu, K. Tsurui, 1990, The Journal of pharmacology and experimental therapeutics.

Change in small intestinal brush border membranes of rats following methotrexate administration.

T. Horie, S. Awazu, K. Tsurui, 1989, Pharmacology & toxicology.

Repeated-dose liver micronucleus assay: an investigation with 2-nitropropane, a hepatocarcinogen.

Kaori Takahashi, T. Araki, Y. Tanabe, 2015, Mutation research. Genetic toxicology and environmental mutagenesis.

A rapid mitochondrial toxicity assay utilizing rapidly changing cell energy metabolism.

T. Araki, K. Tsurui, Osamu Nakazono, 2017, The Journal of toxicological sciences.

Effect of dosing frequency of teriparatide (PTH 1-34) on bone formation in rats: comparison of bone metabolism marker levels.

D. Nakae, C. Jerome, K. Tsurui, 2018, The Journal of toxicological sciences.